As the smallest antibody fragment with specific binding affinity, nanobody-based nuclear medicine has demonstrated significant potential to revolutionize the field of precision medicine, supported by burgeoning preclinical investigations and accumulating clinical evidence. However, the visualization of nanobodies...
molecule drugs have been considered to enhance CAR-T cell therapy [146]. The findings show that the nanobodies-based CAR structure has effectively targeted specific tumors. CAR-T or CAR-NK cells based on nanobodies have shown anti-tumor effects in-vitro and in-vivo. Nanobodies have been use...